Acyclovir Tablet
Product Images NDC 43063-589

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 43063-589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063589 Label (43063589)

43063589 Label (43063589)
Acyclovir USP 800 mg oral tablet packaging label from PD-Rx Pharmaceuticals, Inc. This label includes strength and count information, indicating 35 tablets. It displays NDC 43063-589-35, lot number C22B49, and expiration date 04/2023. The label contains usage warnings and prescribing instructions emphasizing keeping out of reach of children and consulting a doctor for side effects.*
FDA Label Image

Structure.jpg

Structure.jpg
Chemical structure of acyclovir, showing its characteristic purine base with attached side chain and functional groups, corresponding to the active ingredient in Acyclovir 800 mg oral tablets by PD-Rx Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.